Trends in the incidence of transient ischemic attacks, premorbid risk factors and the use of preventive treatments in the population of Dijon, France from 1985 to 2004

Cerebrovasc Dis. 2007;23(2-3):126-31. doi: 10.1159/000097049. Epub 2006 Nov 16.

Abstract

Background: We describe the epidemiological trends of transient ischemic attack (TIA) in a 20-year population-based pilot study.

Methods: Trends in the incidence, risk factors and pre-TIA use of preventive treatments for TIA were observed from 1985 to 2004 according to the classic definition in the population of the city of Dijon, France (150,000 inhabitants).

Results: The raw and standardized incidence of TIA were stable over time. We observed a significant increase in the mean age at TIA onset in women only. The prevalence of hypercholesterolemia and diastolic blood pressure > or =90 mm Hg among patients with TIA increased significantly. This contrasts with falls in smoking and in history of previous myocardial infarction.

Conclusion: The stability of classic TIA incidence, despite the rise in the proportion of elderly people, and the increase in the mean age at onset in women may be considered as a medical progress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Distribution
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Atrial Fibrillation / complications
  • Atrial Fibrillation / drug therapy
  • Atrial Fibrillation / epidemiology*
  • Epidemiology / trends
  • Female
  • France / epidemiology
  • Humans
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / epidemiology*
  • Hypertension / complications
  • Hypertension / drug therapy
  • Hypertension / epidemiology*
  • Incidence
  • Ischemic Attack, Transient / epidemiology*
  • Ischemic Attack, Transient / etiology*
  • Ischemic Attack, Transient / prevention & control
  • Male
  • Middle Aged
  • Myocardial Infarction / complications
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / epidemiology*
  • Pilot Projects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Population Surveillance
  • Registries / statistics & numerical data
  • Risk Factors
  • Sex Distribution
  • Sex Factors
  • Smoking / adverse effects
  • Smoking / epidemiology*
  • Time Factors

Substances

  • Anticoagulants
  • Antihypertensive Agents
  • Platelet Aggregation Inhibitors